22980

    544135

    MUKKA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    MUKKA PROTEINS LIMITED Share Price Today

    MUKKA PROTEINS LIMITED is currently trading at ₹23.13, down by ₹0.37 from the previous close. The stock touched an intraday high of ₹23.77 and a low of ₹22.95 during the latest trading session. Over the past one year, MUKKA PROTEINS LIMITED has delivered a loss of 20.9%, while the stock has declined 5.84% in the last one month.

    MUKKA PROTEINS LIMITED performance

    Today’s low Today’s high
    ₹ 22.95 ₹ 23.77
    ₹ 23.13
    52 week low 52 week high
    ₹ 18.27 ₹ 31.23
    ₹ 23.13
    Open Price ₹ 23.49
    Prev. Close ₹ 23.50
    Volume (Shares) 221656.00
    Total traded value ₹ 51.26
    Upper Circuit ₹ 28.20
    Lower Circuit ₹ 18.80
    info

    Investment Returns

    Over 1 Month -5.84% Over 3 Months -0.50% Over 6 Months 11.63% Over 1 Year -20.90%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    MUKKA PROTEINS LIMITED fundamentals


    • Market cap (Cr) 693.90
    • P/E Ratio (TTM) 16.46
    • Beta 1.08
    • Book Value / share 14.91
    • Return on equity 10.83%
    • EPS (TTM) 1.41
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 18.91
    info icon alternate text
    • Market cap (Cr) 697.80
    • P/E Ratio (TTM) 16.46
    • Beta 1.05
    • Book Value / share 14.91
    • Return on equity 10.83%
    • EPS (TTM) 1.41
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 18.91
    info icon alternate text

    MUKKA PROTEINS LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 300.26
    Operating Expense 300.06
    Net Profit 18.91
    Net Profit Margin (%) 6.29
    Earnings Per Share (EPS) 0.64
    EBITDA 42.91
    Effective Tax Rate (%) 28.93
    Particulars DEC 2025 (Values in Cr)
    Revenue 538.75
    Operating Expense 540.86
    Net Profit 18.76
    Net Profit Margin (%) 3.48
    Earnings Per Share (EPS) 0.63
    EBITDA 39.83
    Effective Tax Rate (%) 23.64
    Particulars SEP 2025 (Values in Cr)
    Revenue 216.04
    Operating Expense 221.92
    Net Profit 3.61
    Net Profit Margin (%) 1.67
    Earnings Per Share (EPS) 0.12
    EBITDA 19.39
    Effective Tax Rate (%) 37.86
    Particulars JUN 2025 (Values in Cr)
    Revenue 129.90
    Operating Expense 136.84
    Net Profit 1.14
    Net Profit Margin (%) 0.87
    Earnings Per Share (EPS) 0.04
    EBITDA 13.51
    Effective Tax Rate (%) 36.66
    Particulars MAR 2025 (Values in Cr)
    Revenue 315.99
    Operating Expense 312.30
    Net Profit 13.09
    Net Profit Margin (%) 4.14
    Earnings Per Share (EPS) 0.43
    EBITDA 27.33
    Effective Tax Rate (%) 23.27
    Particulars MAR 2026 (Values in Cr)
    Revenue 1184.95
    Operating Expense 1199.69
    Net Profit 42.41
    Net Profit Margin (%) 3.57
    Earnings Per Share (EPS) 1.43
    EBITDA 115.63
    Effective Tax Rate (%) 27.84
    Particulars MAR 2025 (Values in Cr)
    Revenue 860.35
    Operating Expense 850.82
    Net Profit 41.68
    Net Profit Margin (%) 4.84
    Earnings Per Share (EPS) 1.39
    EBITDA 92.77
    Effective Tax Rate (%) 20.73
    Particulars MAR 2024 (Values in Cr)
    Revenue 1230.82
    Operating Expense 1216.97
    Net Profit 62.76
    Net Profit Margin (%) 5.09
    Earnings Per Share (EPS) 2.78
    EBITDA 101.46
    Effective Tax Rate (%) 12.40
    Particulars MAR 2023 (Values in Cr)
    Revenue 1045.64
    Operating Expense 1020.17
    Net Profit 39.42
    Net Profit Margin (%) 3.76
    Earnings Per Share (EPS) 1.79
    EBITDA 74.55
    Effective Tax Rate (%) 28.43
    Particulars MAR 2022 (Values in Cr)
    Revenue 692.89
    Operating Expense 672.43
    Net Profit 19.82
    Net Profit Margin (%) 2.86
    Earnings Per Share (EPS) 0.90
    EBITDA 31.91
    Effective Tax Rate (%) 29.71
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 14.69
    ROE % 11.50
    ROCE % 11.75
    Total Debt to Total Equity 0.98
    EBITDA Margin 11.04
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 13.20
    ROE % 27.33
    ROCE % 19.15
    Total Debt to Total Equity 1.15
    EBITDA Margin 9.05
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 6.72
    ROE % 38.62
    ROCE % 24.01
    Total Debt to Total Equity 1.77
    EBITDA Margin 8.01
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 4.47
    ROE % 31.32
    ROCE % 18.20
    Total Debt to Total Equity 2.03
    EBITDA Margin 7.04
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 1209.53
    ROE % 12.53
    ROCE % 9.06
    Total Debt to Total Equity 2.44
    EBITDA Margin 4.58
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 13.48
    ROE % 10.83
    ROCE % 11.41
    Total Debt to Total Equity 0.97
    EBITDA Margin 10.46
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 12.17
    ROE % 25.78
    ROCE % 18.08
    Total Debt to Total Equity 1.17
    EBITDA Margin 8.00
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 5.53
    ROE % 38.66
    ROCE % 23.13
    Total Debt to Total Equity 1.96
    EBITDA Margin 6.99
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 3.74
    ROE % 27.31
    ROCE % 16.76
    Total Debt to Total Equity 1.99
    EBITDA Margin 5.81
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 1142.93
    ROE % 4.29
    ROCE % 5.81
    Total Debt to Total Equity 1.98
    EBITDA Margin 2.51
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 42.28
    Total Assets 1076.32
    Total Liabilities 1076.32
    Total Equity 456.50
    Share Outstanding 30
    Price to Book Ratio 2.43
    Return on Assets (%) 4.31
    Return on Capital (%) 5.12
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 126.80
    Total Assets 940.79
    Total Liabilities 940.79
    Total Equity 408.30
    Share Outstanding 30
    Price to Book Ratio 3.00
    Return on Assets (%) 7.44
    Return on Capital (%) 9.09
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 29.01
    Total Assets 575.16
    Total Liabilities 575.16
    Total Equity 155.84
    Share Outstanding 22
    Price to Book Ratio 0.00
    Return on Assets (%) 7.66
    Return on Capital (%) 10.73
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 13.89
    Total Assets 392.29
    Total Liabilities 392.29
    Total Equity 103.07
    Share Outstanding 22
    Price to Book Ratio 0.00
    Return on Assets (%) 6.17
    Return on Capital (%) 8.75
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 4.18
    Total Assets 354.79
    Total Liabilities 354.79
    Total Equity 69.92
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 2.52
    Return on Capital (%) 3.92
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 39.20
    Total Assets 973.99
    Total Liabilities 973.99
    Total Equity 404.36
    Share Outstanding 30
    Price to Book Ratio 2.43
    Return on Assets (%) 4.27
    Return on Capital (%) 5.09
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 123.50
    Total Assets 851.13
    Total Liabilities 851.13
    Total Equity 365.17
    Share Outstanding 30
    Price to Book Ratio 3.00
    Return on Assets (%) 7.37
    Return on Capital (%) 9.06
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 23.03
    Total Assets 500.03
    Total Liabilities 500.03
    Total Equity 121.63
    Share Outstanding 22
    Price to Book Ratio 0.00
    Return on Assets (%) 7.88
    Return on Capital (%) 11.13
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 8.10
    Total Assets 329.07
    Total Liabilities 329.07
    Total Equity 82.28
    Share Outstanding 22
    Price to Book Ratio 0.00
    Return on Assets (%) 6.02
    Return on Capital (%) 8.16
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 2.07
    Total Assets 288.38
    Total Liabilities 288.38
    Total Equity 62.86
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 1.59
    Return on Capital (%) 2.44
    Particulars MAR 2025 (Values in Cr)
    Net Income 60.26
    Cash from Operations -108.64
    Cash from Investing -34.98
    Cash from Financing 55.55
    Net change in Cash -91.36
    Free Cash Flow -88.60
    Particulars MAR 2024 (Values in Cr)
    Net Income 87.45
    Cash from Operations -124.38
    Cash from Investing -47.59
    Cash from Financing 265.89
    Net change in Cash 67.89
    Free Cash Flow -108.76
    Particulars MAR 2023 (Values in Cr)
    Net Income 65.94
    Cash from Operations -45.19
    Cash from Investing -3.32
    Cash from Financing 74.66
    Net change in Cash 15.01
    Free Cash Flow -36.98
    Particulars MAR 2022 (Values in Cr)
    Net Income 35.98
    Cash from Operations 10.55
    Cash from Investing -11.47
    Cash from Financing 14.99
    Net change in Cash 8.38
    Free Cash Flow 17.06
    Particulars MAR 2021 (Values in Cr)
    Net Income 15.45
    Cash from Operations 6.37
    Cash from Investing -13.61
    Cash from Financing 13.48
    Net change in Cash 1.66
    Free Cash Flow 17.05
    Particulars MAR 2025 (Values in Cr)
    Net Income 52.58
    Cash from Operations -129.75
    Cash from Investing -18.01
    Cash from Financing 59.65
    Net change in Cash -90.74
    Free Cash Flow -124.17
    Particulars MAR 2024 (Values in Cr)
    Net Income 71.64
    Cash from Operations -118.66
    Cash from Investing -46.24
    Cash from Financing 258.05
    Net change in Cash 70.56
    Free Cash Flow -105.77
    Particulars MAR 2023 (Values in Cr)
    Net Income 55.09
    Cash from Operations -38.27
    Cash from Investing 0.71
    Cash from Financing 61.11
    Net change in Cash 14.87
    Free Cash Flow -34.95
    Particulars MAR 2022 (Values in Cr)
    Net Income 28.19
    Cash from Operations -12.96
    Cash from Investing -7.24
    Cash from Financing 27.25
    Net change in Cash 4.70
    Free Cash Flow -10.60
    Particulars MAR 2021 (Values in Cr)
    Net Income 6.05
    Cash from Operations 1.95
    Cash from Investing -5.41
    Cash from Financing 8.05
    Net change in Cash 0.30
    Free Cash Flow 7.36
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    BRITANNIA INDUSTRIES LTD 5467.70 52.01 25.79 131699.56 5038.00 6336.95
    NESTLE INDIA LTD. 1447.70 82.02 54.13 279162.06 1085.00 1498.60
    FOODS & INNS LTD. 57.82 15.34 0.75 425.16 45.00 121.55
    HINDUSTAN UNILEVER LTD. 2139.05 33.00 10.31 502589.32 2023.05 2734.31
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    BRITANNIA INDUSTRIES LTD 5467.70 51.43 28.37 131699.56 5038.00 6336.95
    COLGATE PALMOLIVE LTD. 2113.35 42.77 36.28 57480.08 1781.60 2505.00
    NESTLE INDIA LTD. 1447.70 80.97 52.58 279162.06 1085.00 1498.60
    FOODS & INNS LTD. 57.82 13.57 0.74 425.16 45.00 121.55

    MUKKA PROTEINS LIMITED shareholding pattern

    Holding
    24.93%
    73.33%
    1.73%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    MUKKA PROTEINS LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    23.13 -1.57 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 23.30
    • 26 Days 23.50
    • 10 Days 23.40
    • 50 Days 23.40
    • 12 Days 23.40
    • 100 Days 23.40
    • 20 Days 23.50
    • 200 Days 24.70
    23.27 PIVOT
    First Support 22.74 First Resistance 24.03 Second Support 21.98 Second Resistance 24.56 Third Support 21.45 Third Resistance 25.32
    RSI 50.16 ADX 33.92 MACD -0.07 Williams % R -60.00 Commodity Channel Index (CCI) -73.57
    Date 2026-07-20 Week 124985.00 Same Day 118060.00 Month 133336.00
    1 Year 1.08 3 Year 0.99
    Over 1 Month
    -5.84% down
    Over 1 Year
    -20.90% down
    Over 3 Months
    -0.50% down
    Over 3 Years
    -17.76% down
    Over 6 Months
    11.63% down
    Over 5 Years
    0.00% down

    MUKKA PROTEINS LIMITED Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Mukka Proteins Ltd?

    Answer Field

    Mukka Proteins Ltd share price is for NSE ₹ 23.13 & for BSE ₹ 23.26 as on Jul 21 2026 03:30 PM.

    What is the Market Cap of Mukka Proteins Ltd Share?

    Answer Field

    The market cap of Mukka Proteins Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 21 2026 03:30 PM.

    What is the 52 Week High and Low of Mukka Proteins Ltd?

    Answer Field

    The 52 Week High and Low of Mukka Proteins Ltd for NSE is ₹ 31.23 and ₹ 18.27 and for BSE is ₹ 31.20 and ₹ 18.32.

    What is 1 year return for Mukka Proteins Ltd?

    Answer Field

    The 1 year returns on the stock has been -20.90%.

    What is the P/E Ratio of Mukka Proteins Ltd Share?

    Answer Field

    As on Jul 21 2026 03:30 PM the price-to-earnings (PE) ratio for Mukka Proteins Ltd share is 16.46.

    What is the PB ratio of Mukka Proteins Ltd Share?

    Answer Field

    As on Jul 21 2026 03:30 PM, the price-to-book (PB) ratio for Mukka Proteins Ltd share is 14.91.

    How to Buy Mukka Proteins Ltd Share?

    Answer Field

    You can trade in Mukka Proteins Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Mukka Proteins Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Mukka Proteins Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Mukka Proteins Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |